345495 <common-name>N-[(2s)-1-[[(3s)-3-[(s)-amino(sulfanyl)methyl]-1-benzylpyrrolidin-3-yl]amino]-3-cyclohexyl-1-oxopropan-2-yl]morpholine-4-carboxamide</common-name> <description>N-[(2s)-1-[[(3s)-3-[(s)-amino(sulfanyl)methyl]-1-benzylpyrrolidin-3-yl]amino]-3-cyclohexyl-1-oxopropan-2-yl]morpholine-4-carboxamide is a chemical compound with the formula C26H41N5O3S. With an average molecular weight of 503.70 g/mol, N-[(2s)-1-[[(3s)-3-[(s)-amino(sulfanyl)methyl]-1-benzylpyrrolidin-3-yl]amino]-3-cyclohexyl-1-oxopropan-2-yl]morpholine-4-carboxamide is a heavy molecule.</description> <cas nil="true"/> <pubchem-id>23627196</pubchem-id> <chemical-formula>C26H41N5O3S</chemical-formula> <weight>503.7</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-31T08:17:16Z</created-at> <updated-at type="dateTime">2026-08-31T08:17:16Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>C1CCC(CC1)CC(C(=O)NC2(CCN(C2)CC3=CC=CC=C3)C(N)S)NC(=O)N4CCOCC4</moldb-smiles> <moldb-formula>C26H41N5O3S</moldb-formula> <moldb-inchi>InChI=1S/C26H41N5O3S/c27-24(35)26(11-12-30(19-26)18-21-9-5-2-6-10-21)29-23(32)22(17-20-7-3-1-4-8-20)28-25(33)31-13-15-34-16-14-31/h2,5-6,9-10,20,22,24,35H,1,3-4,7-8,11-19,27H2,(H,28,33)(H,29,32)/t22-,24-,26-/m0/s1</moldb-inchi> <moldb-inchikey>SYYPOPSZUGMAIG-GVUKDKGQSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">503.2930114</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>2.7</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM341388</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>N-[(2s)-1-[[(3s)-3-[(s)-amino(sulfanyl)methyl]-1-benzylpyrrolidin-3-yl]amino]-3-cyclohexyl-1-oxopropan-2-yl]morpholine-4-carboxamide</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Organic acids and derivatives</superklass> <klass>Carboxylic acids and derivatives</klass> <subklass>Amino acids, peptides, and analogues</subklass> <paper-count type="integer" nil="true"/> <sync-id>CED0295852</sync-id> <structure-inchikey>SYYPOPSZUGMAIG-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>60100004000000000400800000100400000000000000000000000020040001000000000100000000000000808000000004000000000000000000000008000000001000000000000400000020000000000020800000000000000000008000000000002000010000000000000000000020000000020100022000000000000000100800000008200020800000000008000080201000000100000000080000020000800000000005000000000000080000040000000040000008008000020000000000000000000000000000000000000000000010000000020000000220041000010000000010000800000040000000000400000000800000000000004000000000</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAjAAAAJgAAAIABBgBgAAAAAgIGAGAAAAAC AgYAYAAAAAICBgBgAAAAAwEGAGAAAAACAgYAYAAAAAICBgBgAAAAAgIGAGAA AAADAQYAKAAAAAMECAAoAAAAAwIHAGgAAAADAgEGACAAAAAEBgBgAAAAAgIG AGAAAAACAgcAIAAAAAMGAGAAAAACAgYAYAAAAAICBkAoAAAAAwQGQGgAAAAD AwEGQGgAAAADAwEGQGgAAAADAwEGQGgAAAADAwEGQGgAAAADAwEGAGAAAAAD AQcAYAAAAAECEABgAAAAAQEHAGgAAAADAgEGACgAAAADBAgAKAAAAAMCBwAo AAAAAwMGAGAAAAACAgYAYAAAAAICCAAgAAAAAgYAYAAAAAICBgBgAAAAAgIL AAEAAQIAAgMAAwQABAUAAwYABgcABwgACAkoAggKIAoLAAsMAAwNAA0OAA4P AA4QABARABESaAwSE2gMExRoDBQVaAwVFmgMCxcAFxgAFxkABxoAGhsgGxwo AhsdIB0eAB4fAB8gACAhACEiAAUAAA8LABYRaAwiHQBCBAAAAAYABQQDAgEF DAsPDg0GEhMUFRYRBh4fICEiHRcEAAAAAAAAABY= </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:44:31Z</structure-indexed-at> </compound>